Report Detail
Global Filgotinib Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4735330 |
- 24 August, 2026 |
- Global |
- 85 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Filgotinib Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Filgotinib tablets are an oral Janus kinase (JAK) inhibitor specifically targeting JAK1, primarily used in the treatment of inflammatory conditions such as rheumatoid arthritis and inflammatory bowel disease.
This report is a detailed and comprehensive analysis for global Filgotinib Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Filgotinib Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Filgotinib Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Filgotinib Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Filgotinib Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Filgotinib Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Filgotinib Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alfasigma, Gilead Sciences, Eisai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Filgotinib Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100mg per Tablet
200mg per Tablet
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Major players covered
Alfasigma
Gilead Sciences
Eisai
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Filgotinib Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Filgotinib Tablets, with price, sales quantity, revenue, and global market share of Filgotinib Tablets from 2021 to 2026.
Chapter 3, the Filgotinib Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Filgotinib Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Filgotinib Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Filgotinib Tablets.
Chapter 14 and 15, to describe Filgotinib Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Filgotinib Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 100mg per Tablet
- 1.3.3 200mg per Tablet
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Filgotinib Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital Pharmacy
- 1.4.3 Retail Pharmacy
- 1.4.4 Online Pharmacy
- 1.5 Global Filgotinib Tablets Market Size & Forecast
- 1.5.1 Global Filgotinib Tablets Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Filgotinib Tablets Sales Quantity (2021-2032)
- 1.5.3 Global Filgotinib Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Alfasigma
- 2.1.1 Alfasigma Details
- 2.1.2 Alfasigma Major Business
- 2.1.3 Alfasigma Filgotinib Tablets Product and Services
- 2.1.4 Alfasigma Filgotinib Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Alfasigma Recent Developments/Updates
- 2.2 Gilead Sciences
- 2.2.1 Gilead Sciences Details
- 2.2.2 Gilead Sciences Major Business
- 2.2.3 Gilead Sciences Filgotinib Tablets Product and Services
- 2.2.4 Gilead Sciences Filgotinib Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Gilead Sciences Recent Developments/Updates
- 2.3 Eisai
- 2.3.1 Eisai Details
- 2.3.2 Eisai Major Business
- 2.3.3 Eisai Filgotinib Tablets Product and Services
- 2.3.4 Eisai Filgotinib Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Eisai Recent Developments/Updates
3 Competitive Environment: Filgotinib Tablets by Manufacturer
- 3.1 Global Filgotinib Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Filgotinib Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Filgotinib Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Filgotinib Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Filgotinib Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Filgotinib Tablets Manufacturer Market Share in 2025
- 3.5 Filgotinib Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Filgotinib Tablets Market: Region Footprint
- 3.5.2 Filgotinib Tablets Market: Company Product Type Footprint
- 3.5.3 Filgotinib Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Filgotinib Tablets Market Size by Region
- 4.1.1 Global Filgotinib Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Filgotinib Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Filgotinib Tablets Average Price by Region (2021-2032)
- 4.2 North America Filgotinib Tablets Consumption Value (2021-2032)
- 4.3 Europe Filgotinib Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Filgotinib Tablets Consumption Value (2021-2032)
- 4.5 South America Filgotinib Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Filgotinib Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Filgotinib Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Filgotinib Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Filgotinib Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Filgotinib Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Filgotinib Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Filgotinib Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Filgotinib Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Filgotinib Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Filgotinib Tablets Market Size by Country
- 7.3.1 North America Filgotinib Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Filgotinib Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Filgotinib Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Filgotinib Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Filgotinib Tablets Market Size by Country
- 8.3.1 Europe Filgotinib Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Filgotinib Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Filgotinib Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Filgotinib Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Filgotinib Tablets Market Size by Region
- 9.3.1 Asia-Pacific Filgotinib Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Filgotinib Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Filgotinib Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Filgotinib Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Filgotinib Tablets Market Size by Country
- 10.3.1 South America Filgotinib Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Filgotinib Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Filgotinib Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Filgotinib Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Filgotinib Tablets Market Size by Country
- 11.3.1 Middle East & Africa Filgotinib Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Filgotinib Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Filgotinib Tablets Market Drivers
- 12.2 Filgotinib Tablets Market Restraints
- 12.3 Filgotinib Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Filgotinib Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Filgotinib Tablets
- 13.3 Filgotinib Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Filgotinib Tablets Typical Distributors
- 14.3 Filgotinib Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Filgotinib Tablets. Industry analysis & Market Report on Filgotinib Tablets is a syndicated market report, published as Global Filgotinib Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Filgotinib Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
